(Updates with company comment in fourth paragraph)
Oct. 13 (Bloomberg) -- Sanofi, France’s biggest drugmaker, plans to raise a 3 billion euros ($4.12 billion) credit line to refinance a deal maturing next year, according to three people with knowledge of the situation.
Royal Bank of Scotland Group Plc, BNP Paribas SA and Societe Generale SA are coordinating the one-year transaction that can be extended by a maximum of two years, said the people, who declined to be identified because the deal is private.
The bank line will replace Sanofi’s 5.8 billion-euro revolving credit signed in 2005, said the people.
Jean-Marc Podvin, a spokesman for the Paris-based company, declined to comment.
--Editor: Faris Khan
To contact the reporters on this story: Patricia Kuo in London at email@example.com; Stephen Morris in London at firstname.lastname@example.org
To contact the editor responsible for this story: Faris Khan at email@example.com